TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06928545: MagDI U.S. Registry

Sponsor: GT Metabolic Solutions, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 106 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$398,400

Rescue Site Savings

+$265,600

Unlock Full NCT06928545 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06928545 Rescue Dossier →